Hematological manifestations of primary mitochondrial disorders
- PMID: 17637511
- DOI: 10.1159/000105676
Hematological manifestations of primary mitochondrial disorders
Abstract
At onset mitochondrial disorders (MID) frequently manifest as a mono-organic problem but turn into multisystem disease during the disease course in most of the cases. Organs/tissues most frequently affected in MID are the cerebrum, peripheral nerves, and the skeletal muscle. Additionally, most of the inner organs may be affected alone or in combination. Hematological manifestations of MID include aplastic, megaloblastic, or sideroblastic anemia, leukopenia, neutropenia, thrombocytopenia, or pancytopenia. In single cases either permanent or recurrent eosinophilia has been observed. Hematological abnormalities may occur together with syndromic or nonsyndromic MIDs. Syndromic MIDs, in which hematological manifestations predominate, are the Pearson syndrome (pancytopenia), Kearns-Sayre syndrome (anemia), Barth syndrome (neutropenia), and the autosomal recessive mitochondrial myopathy, lactic acidosis and sideroblastic anemia syndrome. In single cases with Leigh's syndrome, MERRF (myoclonic epilepsy and ragged-red fiber) syndrome, Leber's hereditary optic neuropathy, and Friedreich's ataxia anemia has been described. Anemia, leukopenia, thrombocytopenia, eosinophilia, or pancytopenia can frequently also be found in nonsyndromic MIDs with or without involvement of other tissues. Therapy of blood cell involvement in MID comprises application of antioxidants, vitamins, iron, bone marrow-stimulating factors, or substitution of cells.
2007 S. Karger AG, Basel
Similar articles
-
Central nervous system manifestations of mitochondrial disorders.Acta Neurol Scand. 2006 Oct;114(4):217-38. doi: 10.1111/j.1600-0404.2006.00671.x. Acta Neurol Scand. 2006. PMID: 16942541 Review.
-
White matter involvement in mitochondrial diseases.Mol Genet Metab. 2005 Feb;84(2):127-36. doi: 10.1016/j.ymgme.2004.09.008. Epub 2004 Dec 10. Mol Genet Metab. 2005. PMID: 15670718 Review.
-
Renal manifestations of primary mitochondrial disorders.Biomed Rep. 2017 May;6(5):487-494. doi: 10.3892/br.2017.892. Epub 2017 Apr 12. Biomed Rep. 2017. PMID: 28515908 Free PMC article.
-
Cognitive dysfunction in mitochondrial disorders.Acta Neurol Scand. 2012 Jul;126(1):1-11. doi: 10.1111/j.1600-0404.2012.01649.x. Epub 2012 Feb 15. Acta Neurol Scand. 2012. PMID: 22335339
-
Peripheral neuropathy of mitochondrial myopathies.Rev Neurol (Paris). 1991;147(6-7):501-7. Rev Neurol (Paris). 1991. PMID: 1660182 Review.
Cited by
-
Multisystem Disease, Including Eosinophilia and Progressive Hyper-Creatine-Kinase-emia over 10 Years, Suggests Mitochondrial Disorder.Case Rep Neurol. 2017 Apr 24;9(1):69-75. doi: 10.1159/000466686. eCollection 2017 Jan-Apr. Case Rep Neurol. 2017. PMID: 28559828 Free PMC article.
-
Hematopoiesis in the thymidine kinase 2 deficient mouse model of mitochondrial DNA depletion syndrome.J Inherit Metab Dis. 2010 Jun;33(3):231-6. doi: 10.1007/s10545-010-9102-x. Epub 2010 May 4. J Inherit Metab Dis. 2010. PMID: 20440651
-
Targeting memory T cell metabolism to improve immunity.J Clin Invest. 2022 Jan 4;132(1):e148546. doi: 10.1172/JCI148546. J Clin Invest. 2022. PMID: 34981777 Free PMC article. Review.
-
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Genet Med. 2015 Sep;17(9):689-701. doi: 10.1038/gim.2014.177. Epub 2014 Dec 11. Genet Med. 2015. PMID: 25503498 Free PMC article. Review.
-
Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach.J Multidiscip Healthc. 2015 Jul 29;8:345-58. doi: 10.2147/JMDH.S54802. eCollection 2015. J Multidiscip Healthc. 2015. PMID: 26251611 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical